Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 2:46 pm Sale |
2023-12-31 | 13G | Greenland Technologies Holding Corporation GTEC |
ARMISTICE CAPITAL LLC | 713,995 4.990% |
-563,312 (-44.10%) |
Filing History |
| 2024-02-14 2:46 pm Purchase |
2023-12-31 | 13G | GT Biopharma, Inc. GTBP |
ARMISTICE CAPITAL LLC | 2,175,358 4.990% |
2,175,358 (New Position) |
Filing History |
| 2024-02-14 2:45 pm Purchase |
2023-12-31 | 13G | Entero Therapeutics, Inc. ENTO |
ARMISTICE CAPITAL LLC | 78,061 4.990% |
78,061 (New Position) |
Filing History |
| 2024-02-14 2:45 pm Sale |
2023-12-31 | 13G | Freshpet, Inc. FRPT |
ARMISTICE CAPITAL LLC | 803,258 1.670% |
-1,332,742 (-62.39%) |
Filing History |
| 2024-02-14 2:44 pm Purchase |
2023-12-31 | 13G | Cyclo Therapeutics, Inc. CYTH |
ARMISTICE CAPITAL LLC | 1,501,625 4.990% |
471,625 (+45.79%) |
Filing History |
| 2024-02-14 2:44 pm Purchase |
2023-12-31 | 13G | Connexa Sports Technologies Inc. YYAI |
ARMISTICE CAPITAL LLC | 1,445 4.990% |
1,445 (New Position) |
Filing History |
| 2024-02-14 2:43 pm Purchase |
2023-12-31 | 13G | Bruush Oral Care Inc. BRSHF |
ARMISTICE CAPITAL LLC | 821,965 1.870% |
821,965 (New Position) |
Filing History |
| 2024-02-14 2:43 pm Purchase |
2023-12-31 | 13G | Biora Therapeutics, Inc. BIOR |
ARMISTICE CAPITAL LLC | 107,490 3.800% |
107,490 (New Position) |
Filing History |
| 2024-02-14 2:42 pm Purchase |
2023-12-31 | 13G | Biodexa Pharmaceuticals Plc BDRX |
ARMISTICE CAPITAL LLC | 998 0.940% |
998 (New Position) |
Filing History |
| 2024-02-14 2:41 pm Purchase |
2023-12-31 | 13G | Avinger, Inc. AVGR |
ARMISTICE CAPITAL LLC | 67,226 4.990% |
67,226 (New Position) |
Filing History |
| 2024-02-14 2:41 pm Sale |
2023-12-31 | 13G | Autolus Therapeutics plc AUTL |
ARMISTICE CAPITAL LLC | 3,850,000 2.210% |
-6,374,000 (-62.34%) |
Filing History |
| 2024-02-14 2:40 pm Sale |
2023-12-31 | 13G | Applied Therapeutics, Inc. APLT |
ARMISTICE CAPITAL LLC | 0 0.000% |
-5,333,951 (Position Closed) |
Filing History |
| 2024-02-14 2:39 pm Sale |
2023-12-31 | 13G | Acurx Pharmaceuticals, Inc. ACXP |
ARMISTICE CAPITAL LLC | 723,104 4.990% |
-156,896 (-17.83%) |
Filing History |
| 2024-02-14 2:38 pm Purchase |
2023-12-31 | 13G | Abeona Therapeutics Inc. ABEO |
ARMISTICE CAPITAL LLC | 1,301,114 4.990% |
195,114 (+17.64%) |
Filing History |
| 2024-02-14 2:35 pm Purchase |
2023-12-31 | 13G | Voyager Therapeutics, Inc. VYGR |
ARMISTICE CAPITAL LLC | 4,236,000 9.630% |
840,000 (+24.73%) |
Filing History |
| 2024-02-14 2:35 pm Purchase |
2023-12-31 | 13G | Travere Therapeutics, Inc. TVTX |
ARMISTICE CAPITAL LLC | 7,384,000 9.830% |
972,000 (+15.16%) |
Filing History |
| 2024-02-14 2:34 pm Purchase |
2023-12-31 | 13G | Trevena, Inc. TRVN |
ARMISTICE CAPITAL LLC | 73,105 9.990% |
41,711 (+132.87%) |
Filing History |
| 2024-02-14 2:34 pm Purchase |
2023-12-31 | 13G | TC Biopharm (Holdings) Plc TCBP |
ARMISTICE CAPITAL LLC | 828 9.990% |
828 (New Position) |
Filing History |
| 2024-02-14 2:33 pm Purchase |
2023-12-31 | 13G | Supernus Pharmaceuticals, Inc. SUPN |
ARMISTICE CAPITAL LLC | 4,650,000 8.510% |
294,000 (+6.75%) |
Filing History |
| 2024-02-14 2:32 pm Purchase |
2023-12-31 | 13G | Presidio Property Trust, Inc. SQFT |
ARMISTICE CAPITAL LLC | 145,726 9.990% |
9,953 (+7.33%) |
Filing History |